Vincent Chow

Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.

Stanley Cohen, R. Labadie, V. Chow, 2010, British journal of clinical pharmacology.